Where to Inject Semaglutide: Stomach, Thigh, or Arm?

Semaglutide is injected subcutaneously into one of three body areas: the abdomen, the front of the thigh, or the upper arm. These are the sites used in clinical trials and specified in prescribing information, and all three deliver the drug effectively into the fatty tissue just beneath the skin. Choosing among them comes down to comfort, body composition, and practical considerations that vary from person to person.

The Three Approved Injection Sites

In the pivotal clinical trials for semaglutide, participants received once-weekly subcutaneous injections in the abdomen, thigh, or upper arm.¹ Each site has a slightly different feel and practical profile:

Abdomen: The area around the belly button, staying at least two inches away from the navel itself. This is the most popular choice for many self-injecting medications because the skin is easy to reach, there is generally a generous layer of subcutaneous fat, and the injection can be done while sitting or standing. People who carry more weight around the midsection tend to find this site the most comfortable.
Thigh: The front or outer middle section of the upper leg. The thigh offers a large surface area and is easy to see, which can be helpful when you are learning to inject. However, subcutaneous tissue tends to be thinner here, and some people report slightly more awareness of the needle compared to the abdomen.
Upper arm: The back or outer part of the upper arm. This site works well but is harder to reach on your own, so it is often used when a caregiver or partner is giving the injection. The fatty layer on the back of the arm varies quite a bit from person to person.

All three sites are considered equally acceptable. You do not need to stick with the same one every week, and in fact rotating is generally recommended. The key requirement is that the injection goes into subcutaneous tissue rather than muscle.

Does the Injection Site Affect How Well the Drug Works?

A pharmacokinetic analysis of semaglutide found only minor differences in bioavailability between injection sites.² In practical terms, this means you will get a comparable drug effect whether you inject in the abdomen, thigh, or upper arm. The differences were small enough that the prescribing information does not tell you to prefer one site over another for efficacy reasons.

This is reassuring but worth understanding in context. Semaglutide is a long-acting medication designed to release slowly from the subcutaneous depot over the course of a week. That slow-release pharmacology makes it forgiving about minor variations in absorption speed between sites. If one site absorbs a tiny bit faster or slower, the overall weekly drug exposure stays close to equivalent. This stands in contrast to some rapid-acting injectable medications where site selection can meaningfully change how quickly the drug hits peak levels.

Why Subcutaneous Depth Matters

The goal of a subcutaneous injection is to place the medication in the fatty layer between the skin and the underlying muscle. If the needle goes too deep and enters muscle tissue, the drug absorbs differently, and you may also experience more bruising or soreness. How much subcutaneous tissue sits between your skin and muscle depends on where on your body you are injecting, your body mass index, and your sex.

Research using ultrasound measurements in adults found that the distance from skin surface to muscle varies considerably by site. Median distances ranged from about 11 mm at the thigh to roughly 17 mm at the buttock, with the abdomen and arm falling in between.³ Women generally have thicker subcutaneous tissue than men across all sites and BMI ranges.⁴ Higher BMI also corresponds to greater subcutaneous thickness.

The thigh consistently has the thinnest subcutaneous layer. In the ultrasound study, the minimum skin-to-muscle distance at the thigh was under 3 mm in some individuals, meaning a very lean person injecting in the thigh with a longer needle could inadvertently reach muscle.⁵ The semaglutide pen-injectors use relatively short needles precisely to reduce this risk. If you are lean and prefer the thigh, pinching a fold of skin before inserting the needle can help ensure the medication stays in the fatty layer.

How Body Size and Sex Influence Site Choice

Because subcutaneous tissue thickness increases with BMI, people with higher body weight generally have more flexibility. Nearly any of the three sites will offer a generous subcutaneous cushion, and the risk of accidentally injecting into muscle is low. For someone with a BMI in the lower-normal range, especially a man with less peripheral fat, the abdomen tends to be the safest bet because it usually retains more subcutaneous tissue even in lean individuals.

The arm site shows the widest range of subcutaneous thickness. Measurements in one study found combined skin and subcutaneous tissue thickness at the arm ranged from just over 2 mm in lean males to 21 mm in females with higher BMI.⁶ That enormous spread means the upper arm is a perfectly fine site for many people but a poor choice for someone with very little arm fat, unless the skin is pinched up during injection.

For children and adolescents, the picture shifts further. Research on younger patients found that the risk of intramuscular injection was quite high at certain sites, particularly the abdomen in young children and the arm and thigh in teenagers, even with short 4 mm needles.⁷ Since semaglutide has received approval for adolescents in some indications, site selection and technique guidance from a healthcare provider becomes especially important in younger patients.

Practical Injection Technique

The semaglutide pen comes pre-filled and uses a fine, short needle that attaches before each injection. Here is the general approach that applies regardless of which site you choose:

Clean the area: Wipe the injection site with an alcohol swab and let it air dry. Injecting through wet alcohol can sting.
Pinch if needed: If you are lean or using the thigh or arm, gently pinch a fold of skin between your thumb and forefinger. This lifts the subcutaneous layer away from the muscle. People with more body fat can inject without a pinch.
Insert at 90 degrees: Hold the pen perpendicular to the skin and press the needle in. The pen’s needle is designed to reach subcutaneous tissue at this angle in most adults.
Hold after clicking: After pressing the injection button, keep the needle in place for several seconds (the specific duration is in your pen’s instructions) so the full dose is delivered. Withdrawing too quickly can cause some medication to leak back out.
Do not rub: After removing the needle, you can press lightly with a cotton ball if there is a drop of blood, but avoid massaging the site. Rubbing can increase bruising and may affect absorption.

The force you apply when pressing the pen against your skin also plays a role. Research on autoinjector-style devices found that pressing harder compresses the tissue and effectively increases how deep the needle reaches, with injection depth exceeding needle length by several millimeters under higher applied force.⁸ A gentle, steady press is better than jamming the pen in aggressively, particularly in areas where the subcutaneous layer is thinner.

Why You Should Rotate Injection Sites

Repeatedly injecting in the exact same spot can cause localized changes in the fat tissue beneath the skin. With insulin injections, this phenomenon is well documented: lumps of hardened or shrunken fat can form, and the drug absorbs erratically from damaged tissue. While the evidence is less extensive for once-weekly semaglutide than for daily insulin, the same biological principle applies. Rotating between sites and even between different spots within the same site helps keep the tissue healthy.

A practical rotation scheme might look like this: abdomen one week, right thigh the next, left thigh the following week, then back to the abdomen but a different spot. You do not need a rigid schedule, just avoid hitting the same square inch repeatedly. Some people find it helpful to mentally divide their abdomen into quadrants and move clockwise from week to week.

If you notice a small hard lump or a spot that stays tender between injections, avoid that area for several weeks. These nodules usually resolve on their own once the tissue gets a break.

Injection Site Reactions and What to Expect

Reactions at the injection site are among the more common side effects of semaglutide and similar medications. Localized redness, swelling, itching, and mild pain at the spot where the needle went in have been reported in up to about 20% of people using GLP-1 receptor agonist medications.⁹ The most commonly reported skin reactions include itching, redness, and rash at the injection site.¹⁰

For most people, these reactions are mild and short-lived, resolving within a day or two. They tend to be more noticeable during the first few weeks of treatment and often fade as the body adjusts. If reactions persist or worsen, switching to a different injection site sometimes helps, because skin sensitivity can vary across body areas. Persistent or spreading reactions that go beyond the immediate injection site warrant a conversation with your prescriber, as rare cases of delayed hypersensitivity have been reported with GLP-1 receptor agonist medications.

Cold medication tends to sting more. If you store your pen in the refrigerator, letting it sit at room temperature for about 30 minutes before injecting can reduce discomfort. The solution should be clear and colorless; if it looks cloudy or has particles, do not use it.

How Painful Is the Injection?

Semaglutide injections are generally well tolerated in terms of pain. In a head-to-head comparison against another weekly injectable (dulaglutide), semaglutide scored considerably lower on a pain scale, with an average pain intensity of about 5.6 mm on a 100-mm scale compared to 11.5 mm for the comparator. Pain also lasted roughly half as long, averaging about 16 seconds versus 32 seconds.¹¹ For context, a 5.6 mm score on a 100-point scale is barely perceptible to most people. Many users describe the sensation as less painful than a finger prick for blood sugar testing.

Pain can vary by site. The abdomen, with its generally thicker fat layer, tends to be the least sensitive for many people. The thigh can be slightly more noticeable, especially if you hit an area closer to the muscle. The upper arm falls somewhere in between but is hard to assess when you are doing it yourself since the awkward reach can make the experience feel clumsier. If one site consistently bothers you, simply switch to a different one.

The Dose Escalation Schedule and Its Relationship to Injection Sites

Semaglutide starts at a low dose and ramps up gradually. In the weight management trials, participants began at 0.25 mg weekly for four weeks, then moved to 0.5 mg, then 0.75 mg, then 1.7 mg, each for four-week stretches, before reaching the maintenance dose of 2.4 mg by around week 16.¹² The type 2 diabetes formulation follows a similar but somewhat shorter escalation to its target dose of 1.0 mg or 2.0 mg.

This gradual ramp-up is designed to reduce gastrointestinal side effects like nausea. But it also has a subtle connection to injection sites: as you gain experience over those first several weeks at lower doses, you naturally learn which site feels most comfortable for you. Some people discover that the abdomen works best during the early weeks when they are still getting used to the process, then branch out to the thigh or arm once they feel more confident. There is no clinical reason to change sites as the dose increases, but many people settle into a preference during the escalation period.

Sites You Should Avoid

A few locations are off-limits for subcutaneous injection, and the reasons are straightforward:

Within two inches of the navel: The tissue around the belly button is denser and more fibrous, leading to unpredictable absorption and more pain.
Scar tissue or stretch marks: Scarred skin has altered blood flow and tissue architecture, which can affect how the drug is absorbed.
Areas with visible veins: Hitting a vein means the medication enters the bloodstream directly rather than forming a slow-release subcutaneous depot.
Bruised, tender, or hardened areas: These indicate tissue damage from a previous injection or another cause. Injecting into already-irritated tissue increases discomfort and can worsen local reactions.
Tattoos: Freshly inked skin is healing and should not be punctured. Even healed tattoos may have altered tissue properties, though this is more of a theoretical concern than a well-studied risk. Many people with tattoos inject through them without issues, but if you have an alternative site, it is the simpler choice.

The buttock, despite having a thick subcutaneous layer, is not listed among the approved injection sites for semaglutide. It was not studied in the clinical trials, and reaching it comfortably for self-injection is difficult. Some healthcare providers are flexible about this, but the formal guidance sticks with abdomen, thigh, and upper arm.

Injection Site Reactions Compared Across Similar Medications

If you are considering semaglutide alongside other injectable weight-loss or diabetes medications, injection site reactions are worth comparing. A systematic review of tirzepatide, a newer dual-action injectable, found no statistically significant difference in the rate of injection site reactions compared to GLP-1 receptor agonists like semaglutide.¹³ In other words, switching between these medications is unlikely to solve an injection site reaction problem, since the rates are comparable. The reactions appear to be a feature of injecting a peptide into subcutaneous tissue rather than something unique to any one drug.

Where semaglutide does appear to have an edge is in injection comfort. The head-to-head trial against dulaglutide showing lower pain scores and shorter pain duration for semaglutide suggests that the pen design and formulation make a meaningful difference in the moment-to-moment experience, even if the longer-term skin reaction rates are similar across the class.¹⁴

When Someone Else Gives the Injection

If a caregiver, partner, or family member is administering the injection, the upper arm becomes a much more practical option. It is the one site that is genuinely difficult to reach on your own but very easy for another person to access. The person giving the injection can clearly see the site, pinch the skin if needed, and hold the pen steady at the correct angle without the awkward contortions required for self-injection in the arm.

For people with limited hand dexterity, arthritis, or visual impairment, having someone else give the injection also reduces the risk of technique errors like inserting the needle at a wrong angle or not holding it in long enough. The semaglutide pen is designed to be user-friendly, but any device that involves small buttons and needle caps can be challenging for people with fine motor difficulties. In those cases, having a second person handle the pen while the patient simply exposes the injection site is a practical arrangement that does not compromise the medication’s effectiveness.

Healthcare professionals sometimes give the first injection during an office visit so the patient can see the technique demonstrated in real time before trying it at home. This is worth requesting if you are anxious about self-injection or if you want guidance on which specific spot on your chosen site looks best given your body composition.